FDA Inspection 1077899 — Glatt Pharmaceutical Services GmbH & Co. KG
The FDA completed an inspection of Glatt Pharmaceutical Services GmbH & Co. KG on Dec 20, 2018 in Binzen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Binzen (Germany)